Literature DB >> 183803

Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a "hit and run" mechanism.

G R Skinner.   

Abstract

The phenomenon of cell transformation by type 2 herpes simplex virus has been investigated. Primary hamster embryo fibroblasts were exposed to type 2 herpes virus under conditions which would restrict or inhibit the lytic events of virus-cell interaction. Cell lines were established by single-cell cloning. There was evidence of altered cell morphology with altered biological activity in terms of longevity and oncogenicity; there was, however, no evidence of virus specific antigen or incorporation of viral nucleic acid into the host cell genome. Virus specific antigen was only detected in the early passages of an uncloned transformed cell line. We are thus unable to confirm previous studies (vide supra) and are obliged to propose a "hit and run" model for in vitro cell transformation by type 2 herpes simplex virus.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 183803      PMCID: PMC2041152     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  54 in total

1.  The structure and biological properties of herpes simplex virus DNA.

Authors:  N M Wilkie; J B Clements; J C Macnab; J H Subak-Sharpe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

2.  Cytology and histopathology of cervical herpes simplex infection.

Authors:  Z M Naib; A J Nahmias; W E Josey
Journal:  Cancer       Date:  1966-07       Impact factor: 6.860

3.  Induction of cell division in medium lacking serum growth factor by SV40.

Authors:  H S Smith; C D Scher; G J Todaro
Journal:  Virology       Date:  1971-05       Impact factor: 3.616

4.  SV40 T antigen induction and transformation in human fibroblast cell strains.

Authors:  S A Aaronson; G J Todaro
Journal:  Virology       Date:  1968-10       Impact factor: 3.616

5.  Sarcomas after inoculation of newborn hamsters with Herpes virus hominis type 2 strains.

Authors:  A J Nahmias; Z M Naib; W E Josey; F A Murphy; C F Luce
Journal:  Proc Soc Exp Biol Med       Date:  1970-09

6.  Inactivation, by UV-, x-, and gamma-radiations, of the infecting and transforming capacities of polyoma virus.

Authors:  R Latarjet; R Cramer; L Montagnier
Journal:  Virology       Date:  1967-09       Impact factor: 3.616

7.  Virus specific antigens in mammalian cells infected with herpes simplex virus.

Authors:  D H Watson; W I Shedden; A Elliot; T Tetsuka; P Wildy; D Bourgaux-Ramoisy; E Gold
Journal:  Immunology       Date:  1966-10       Impact factor: 7.397

8.  Properties of hamster embryo fibroblasts transformed in vitro after exposure to ultraviolet-irradiated herpes simplex virus type 2.

Authors:  R Duff; F Rapp
Journal:  J Virol       Date:  1971-10       Impact factor: 5.103

9.  Herpesvirus type 2: association with carcinoma of the cervix.

Authors:  W E Rawls; W A Tompkins; M E Figueroa; J L Melnick
Journal:  Science       Date:  1968-09-20       Impact factor: 47.728

10.  Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections.

Authors:  A J Nahmias; W E Josey; Z M Naib; C F Luce; A Duffey
Journal:  Am J Epidemiol       Date:  1970-06       Impact factor: 4.897

View more
  25 in total

1.  "Hit-and-run" transformation by adenovirus oncogenes.

Authors:  M Nevels; B Täuber; T Spruss; H Wolf; T Dobner
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Preparation and efficacy of an inactivated subunit vaccine (NFUIBHK) against type 2 Herpes simplex virus infection.

Authors:  G R Skinner; D R Williams; A Buchan; J Whitney; M Harding; K Bodfish
Journal:  Med Microbiol Immunol       Date:  1978-11-17       Impact factor: 3.402

3.  Plasmid mediated mutagenesis of a cellular gene in transfected eukaryotic cells.

Authors:  C R Brandt; F M Buonaguro; J K McDougall; D A Galloway
Journal:  Nucleic Acids Res       Date:  1987-01-26       Impact factor: 16.971

4.  Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.

Authors:  G R Skinner; C B Woodman; C E Hartley; A Buchan; A Fuller; J Durham; M Synnott; J C Clay; J Melling; C Wiblin; J Wilkins
Journal:  Br J Vener Dis       Date:  1982-12

5.  Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection.

Authors:  G R Skinner; A Buchan; D Williams; J Marsden; C Hartley; G Wilbanks; M Turyk; E S Namkoong
Journal:  Br J Exp Pathol       Date:  1982-08

6.  Herpes simplex virus type 2 mutagenesis: characterization of mutants induced at the hprt locus of nonpermissive XC cells.

Authors:  L Pilon; Y Langelier; A Royal
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

7.  Transformation of rabbit vascular smooth muscle cells by human cytomegalovirus morphological transforming region I.

Authors:  A Legrand; E P Mayer; S S Dalvi; M Nachtigal
Journal:  Am J Pathol       Date:  1997-11       Impact factor: 4.307

8.  The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.

Authors:  G R Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

9.  Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.

Authors:  G R Skinner; J E Whitney; C Hartley
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

10.  Viral categorization and discovery in human circulation by transcriptome sequencing.

Authors:  Weihua Wang; Xiaoan Zhang; Yanjuan Xu; Adrian M Di Bisceglie; Xiaofeng Fan
Journal:  Biochem Biophys Res Commun       Date:  2013-06-11       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.